In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment

INTRODUCTION: Breast cancer is among the most prevalent mortal cancers in women worldwide. In the present study, an optimum formulation of letrozole, letrozole-loaded niosome, and empty niosome was developed, and the anticancer effect was assessed in in vitro MCF-7, MCF10A and MDA-MB-231 breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadi, Saeedeh, Seraj, Mahmoud, Chiani, Mohsen, Hosseini, Seyedayin, Bazzazan, Saba, Akbarzadeh, Iman, Saffar, Samaneh, Mostafavi, Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753765/
https://www.ncbi.nlm.nih.gov/pubmed/36531115
http://dx.doi.org/10.2147/IJN.S384085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753765/
https://www.ncbi.nlm.nih.gov/pubmed/36531115
http://dx.doi.org/10.2147/IJN.S384085

Ejemplares similares